These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 28816162)

  • 1. Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
    Yorke ED; Jackson A; Kuo LC; Ojo A; Panchoo K; Adusumilli P; Zauderer MG; Rusch VW; Shepherd A; Rimner A
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):61-69. PubMed ID: 28816162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.
    Thompson MR; Dumane VA; Lazarev SA; Zia Y; Rosenzweig KE
    Pract Radiat Oncol; 2019 May; 9(3):e331-e337. PubMed ID: 30654090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geometric dose prediction model for hemithoracic intensity-modulated radiation therapy in mesothelioma patients with two intact lungs.
    Kuo L; Yorke ED; Dumane VA; Foster A; Zhang Z; Mechalakos JG; Wu AJ; Rosenzweig KE; Rimner A
    J Appl Clin Med Phys; 2016 May; 17(3):371-379. PubMed ID: 27167294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.
    Rimner A; Zauderer MG; Gomez DR; Adusumilli PS; Parhar PK; Wu AJ; Woo KM; Shen R; Ginsberg MS; Yorke ED; Rice DC; Tsao AS; Rosenzweig KE; Rusch VW; Krug LM
    J Clin Oncol; 2016 Aug; 34(23):2761-8. PubMed ID: 27325859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients.
    Meng Y; Yang H; Wang W; Tang X; Jiang C; Shen Y; Luo W
    Radiat Oncol; 2019 Jan; 14(1):7. PubMed ID: 30642354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study.
    Botticella A; Defraene G; Nackaerts K; Deroose C; Coolen J; Nafteux P; Vanstraelen B; Joosten S; Michiels LAW; Peeters S; De Ruysscher D
    Strahlenther Onkol; 2017 Apr; 193(4):285-294. PubMed ID: 28197653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.
    Leitzen C; Wilhelm-Buchstab T; Stumpf S; Heimann M; Koch D; Schmeel C; Simon B; Vornholt S; Garbe S; Röhner F; Schoroth F; Schild HH; Schüller H; Müdder T
    Strahlenther Onkol; 2019 Jul; 195(7):668-676. PubMed ID: 30915490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma.
    Ulger S; Cetin E; Catli S; Sarac H; Kilic D; Bora H
    Technol Cancer Res Treat; 2017 Jun; 16(3):332-338. PubMed ID: 28462689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Kristensen CA; Nøttrup TJ; Berthelsen AK; Kjaer-Kristoffersen F; Ravn J; Sørensen JB; Engelholm SA
    Radiother Oncol; 2009 Jul; 92(1):96-9. PubMed ID: 19364621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.
    Krayenbuehl J; Hartmann M; Lomax AJ; Kloeck S; Hug EB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):628-34. PubMed ID: 20385451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment.
    Lorentini S; Amichetti M; Spiazzi L; Tonoli S; Magrini SM; Fellin F; Schwarz M
    Strahlenther Onkol; 2012 Mar; 188(3):216-25. PubMed ID: 22318326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensator-based intensity-modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy.
    Javedan K; Stevens CW; Forster KM
    J Appl Clin Med Phys; 2008 Oct; 9(4):98-109. PubMed ID: 19020484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
    Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current readings: improvements in intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Rosenzweig KE
    Semin Thorac Cardiovasc Surg; 2013; 25(3):245-50. PubMed ID: 24331147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.
    Ho AY; Ballangrud A; Li G; Gupta GP; McCormick B; Gewanter R; Gelblum D; Zinovoy M; Mueller B; Mychalczak B; Dutta P; Borofsky K; Parhar P; Reyngold M; Braunstein LZ; Chawla M; Krause K; Freeman N; Siu CT; Cost Z; Arnold BB; Zhang Z; Powell SN
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1100-1108. PubMed ID: 30508620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of virtual block objects in reducing the lung dose in helical tomotherapy planning for cervical oesophageal cancer: a planning study.
    Ito M; Shimizu H; Aoyama T; Tachibana H; Tomita N; Makita C; Koide Y; Kato D; Ishiguchi T; Kodaira T
    Radiat Oncol; 2018 Apr; 13(1):62. PubMed ID: 29618353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric comparison of intensity-modulated radiotherapy plans, with or without anterior myocardial territory and left ventricle as organs at risk, in early-stage left-sided breast cancer patients.
    Tan W; Wang X; Qiu D; Liu D; Jia S; Zeng F; Chen Z; Li B; Xu J; Wei L; Hu D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1544-51. PubMed ID: 21470785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.
    Minatel E; Trovo M; Polesel J; Rumeileh IA; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Drigo A; Dassie A; Pagan V; Trovo MG
    J Thorac Oncol; 2012 Dec; 7(12):1862-1866. PubMed ID: 23154558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.